2009
DOI: 10.1080/02841860902974175
|View full text |Cite
|
Sign up to set email alerts
|

Apoptosis in cancer: Key molecular signaling pathways and therapy targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
143
0
5

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 200 publications
(150 citation statements)
references
References 71 publications
2
143
0
5
Order By: Relevance
“…6). It was reported that apoptosis can be induced through caspases-independent pathways, directly through AIF or Endo G release from mitochondria leading to apoptosis (49).…”
Section: Discussionmentioning
confidence: 99%
“…6). It was reported that apoptosis can be induced through caspases-independent pathways, directly through AIF or Endo G release from mitochondria leading to apoptosis (49).…”
Section: Discussionmentioning
confidence: 99%
“…IAPs and Bcl-2 (Burz, Berindan-Neagoe et al 2009). Among IAPs, cIAP-1 and cIAP-2 play key roles in the regulation of death-receptor-mediated apoptosis, whereas the X-linked IAP (XIAP) inhibits death-receptor-as well as mitochondria-mediated apoptosis by inhibiting caspase-3/-7 and caspase-9, key regulators for apoptosis (Chai, Shiozaki et al 2001).…”
Section: Escin Induces Cell Cycle Arrest At G2/m Phase and Modulates mentioning
confidence: 99%
“…These damages lead to cell death apoptosis, when the capacities of cells for repairing damages and for detoxifying ROS are exceeded (Bellance, 2009;Gogvadze, 2009;Grüning, 2010;Israël, 2004Israël, , 2005Kroemer & Pouyssegur, 2008;Olovnikov, 2009;Vander Heiden, 2009). Cells may also develop drug resistance by over expressing anti-apoptotic proteins (Burz, 2009;Green, 2004;Yip, 2008), or by over expressing the transporter Pglycoprotein 170, a protein which expels the chemotherapy drug outside at their membrane. This membrane carrier belongs to the family of the ATP transporters associated with the Multi Drug Resistance phenotype (MDR) (Comerford, 2002).…”
Section: Discussionmentioning
confidence: 99%